Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
LetterLetter to the Editor

Response to “Clinical Relevance of CYP3A5 Genotype on Maraviroc Exposures”

Yanhui Lu, Edward J. Fuchs, Craig W. Hendrix and Namandjé N. Bumpus
Drug Metabolism and Disposition May 2015, 43 (5) 773; DOI: https://doi.org/10.1124/dmd.115.064188
Yanhui Lu
Division of Clinical Pharmacology, Departments of Medicine (Y.L., E.J.F., C.W.H., N.N.B.) and Pharmacology and Molecular Sciences (Y.L., C.W.H., N.N.B.), Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward J. Fuchs
Division of Clinical Pharmacology, Departments of Medicine (Y.L., E.J.F., C.W.H., N.N.B.) and Pharmacology and Molecular Sciences (Y.L., C.W.H., N.N.B.), Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig W. Hendrix
Division of Clinical Pharmacology, Departments of Medicine (Y.L., E.J.F., C.W.H., N.N.B.) and Pharmacology and Molecular Sciences (Y.L., C.W.H., N.N.B.), Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Namandjé N. Bumpus
Division of Clinical Pharmacology, Departments of Medicine (Y.L., E.J.F., C.W.H., N.N.B.) and Pharmacology and Molecular Sciences (Y.L., C.W.H., N.N.B.), Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 43 no. 5 773
DOI 
https://doi.org/10.1124/dmd.115.064188
PubMed 
25838403

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Published online April 1, 2015.

Copyright & Usage 
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Yanhui Lu,
  2. Edward J. Fuchs,
  3. Craig W. Hendrix, and
  4. Namandjé N. Bumpus
  1. Division of Clinical Pharmacology, Departments of Medicine (Y.L., E.J.F., C.W.H., N.N.B.) and Pharmacology and Molecular Sciences (Y.L., C.W.H., N.N.B.), Johns Hopkins University School of Medicine, Baltimore, Maryland
  1. Address correspondence to:
    Dr. Namandjé N. Bumpus, Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, 725 N. Wolfe St., Biophysics 307-A, Baltimore, MD 21205. E-mail: nbumpus1{at}jhmi.edu

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to May 2023

AbstractFullPdf
Aug 2017050
Sep 20170172
Oct 20170144
Nov 20170103
Dec 20170181
Jan 20180123
Feb 20180122
Mar 2018081
Apr 20180174
May 2018081
Jun 20180141
Jul 20180153
Aug 2018060
Sep 20180151
Oct 2018061
Nov 20180100
Dec 2018071
Jan 2019080
Feb 2019046
Mar 20190716
Apr 2019077
May 2019046
Jun 2019055
Jul 2019084
Aug 20190123
Oct 2019094
Nov 2019095
Dec 20190106
Jan 2020035
Feb 2020081
Mar 20200143
May 2020022
Jun 2020054
Jul 2020081
Aug 2020022
Sep 2020033
Oct 2020070
Nov 2020046
Dec 2020062
Jan 2021073
Feb 2021084
Mar 2021078
Apr 2021021
May 2021021
Jun 2021010
Jul 2021010
Aug 2021010
Sep 2021010
Oct 2021010
Nov 2021010
Dec 2021022
Jan 2022021
Feb 2022010
Mar 2022021
Apr 2022043
May 2022010
Jun 2022022
Jul 2022021
Aug 2022010
Sep 2022021
Oct 2022010
Nov 2022020
Dec 2022010
Jan 2023010
Feb 2023020
Mar 2023010
Apr 2023010
May 2023010

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 43 (5)
Drug Metabolism and Disposition
Vol. 43, Issue 5
1 May 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Response to “Clinical Relevance of CYP3A5 Genotype on Maraviroc Exposures”
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
LetterLetter to the Editor

Maraviroc and CYP3A5 Genotype

Yanhui Lu, Edward J. Fuchs, Craig W. Hendrix and Namandjé N. Bumpus
Drug Metabolism and Disposition May 1, 2015, 43 (5) 773; DOI: https://doi.org/10.1124/dmd.115.064188

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
LetterLetter to the Editor

Maraviroc and CYP3A5 Genotype

Yanhui Lu, Edward J. Fuchs, Craig W. Hendrix and Namandjé N. Bumpus
Drug Metabolism and Disposition May 1, 2015, 43 (5) 773; DOI: https://doi.org/10.1124/dmd.115.064188
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Unbound Maximum Hepatic Inlet Concentration
  • Misidentification of Bupropion Glucuronide Metabolites
  • Response to Letter to the Editor
Show more Letters to the Editor

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics